Skip to main content
. 2022 May 2;12:882661. doi: 10.3389/fcimb.2022.882661

Figure 2.

Figure 2

Metabolomic alternations associated with clinical symptoms of COVID-19 compared with healthy control. (A) PCA analysis. (B) OPLS-DA analysis. (C) Permutation analysis. Metabolomic alternations between severe group and healthy control. (D) PCA analysis. (E) OPLS-DA analysis. (F) Permutation analysis. Metabolomic alternations between critical group and healthy control. (G) PCA analysis. (H) OPLS-DA analysis. (I) Permutation analysis.